Lucas J J, Szepesi A, Modiano J F, Domenico J, Gelfand E W
Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206, USA.
J Immunol. 1995 Jun 15;154(12):6275-84.
The PLSTIRE protein (cyclin-dependent kinase 6 (cdk6)), which shares extensive sequence homology (approximately 70%) with cdk4, was identified as the earliest inducible member of the cdk family of proteins in human T lymphocytes induced to proliferate in vitro by stimulation either with phorbol 12,13-dibutyrate and ionomycin (PDB/I) or PHA. The p40cdk6 protein was present in resting cells and increased amounts were detected 6 h after stimulation. It increased in amount throughout the first cell cycle but was present in reduced amounts at later times. Activity of the kinase, determined by in vitro phosphorylation of recombinant truncated retinoblastoma tumor suppressor gene (Rb) protein (p60Rb), paralleled p40cdk6 protein amounts. Cyclins D2 and D3 were the major cyclins associated with p40cdk6, with D2 predominating in early G1 phase. Both PDB and ionomycin were required for maximal accumulation of p40cdk6, but either agent alone stimulated some increase in amount and activity of the protein. p40cdk6 also increased in amount in cells activated in the presence of cyclosporin A or FK506, drugs that inhibit production of IL-2 and cell proliferation, suggesting that initial induction occurred independently of IL-2-mediated cell cycle progression. Furthermore, increased accumulation of p40cdk6 protein and activity occurred in cells rendered "competent" (responsive to IL-2) by a brief treatment with PDB/I. Thus, increased accumulation of the protein and its activity begin before IL-2/IL-2 receptor interaction, suggesting that the cdk6-cyclin D2 complex might be involved in acquisition of the competent state in human T lymphocytes.
PLSTIRE蛋白(细胞周期蛋白依赖性激酶6(cdk6))与cdk4具有广泛的序列同源性(约70%),被确定为在体外经佛波醇12,13 - 二丁酸酯和离子霉素(PDB/I)或PHA刺激诱导增殖的人T淋巴细胞中,cdk蛋白家族最早可诱导的成员。p40cdk6蛋白存在于静息细胞中,刺激后6小时检测到其含量增加。在整个第一个细胞周期中其含量都在增加,但在随后的时间里含量减少。通过重组截短的视网膜母细胞瘤肿瘤抑制基因(Rb)蛋白(p60Rb)的体外磷酸化测定的激酶活性与p40cdk6蛋白含量平行。细胞周期蛋白D2和D3是与p40cdk6相关的主要细胞周期蛋白,D2在G1早期占主导。PDB和离子霉素都是p40cdk6最大积累所必需的,但单独使用任何一种试剂都能刺激该蛋白的含量和活性有所增加。在存在环孢素A或FK506(抑制IL - 2产生和细胞增殖的药物)的情况下激活的细胞中,p40cdk6的含量也增加,这表明最初的诱导发生与IL - 2介导的细胞周期进程无关。此外,通过用PDB/I短暂处理使细胞“致敏”(对IL - 2有反应)后,p40cdk6蛋白和活性的积累增加。因此,该蛋白及其活性的积累增加在IL - 2/IL - 2受体相互作用之前就开始了,这表明cdk6 - 细胞周期蛋白D2复合物可能参与人T淋巴细胞致敏状态的获得。